use in Biological Technology

DOE awards $377 million in funding for 46 energy frontier research centers

... breakthroughs that are essential to expand the use of clean and renewable energy." Of the $377 ... (Amherst, MA) $16 million for five years to use novel, self-assembled polymer materials in ... to identify key features for their potential use as materials to convert solar energy and heat to ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

... from our Phase II clinical trial evaluating the use of CPP-109 for the treatment of cocaine addiction and our proof-of-concept study evaluating the use of CPP-109 for the treatment of methamphetamine ... in the United States relating to the right to use vigabatrin to treat a wide variety of substance ...

GenVec Reports Second Quarter 2009 Financial Results

... or Canada) or 617-213-4846 (international) and use access code 57544597. Participants may ... Pre-registrants will be issued a PIN number to use when dialing into the live call, which will ... or Canada) or 617-801-6888 (international) and use access code 93256887. A live webcast of ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... Option(TM) Inferior Vena Cava ("IVC") Filter, for use in both permanent and retrievable indications. We ... product easier for a physician to use, and the use of non-thrombogenic material which reduces the ... small coronary vessels. It was approved for use in vessels as small as 2.25 mm in diameter and ...

The Breast Cancer Therapeutics Market in Australia

... breast cancer patients in the country. The use of molecular targeted therapies as effective ... now. This may be attributed to the fact that the use of targeted therapy is limited due to access and ... compared to cytotoxic and hormonal therapies, the use of targeted therapies in Australia is and will ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... elements of its pivotal trial, including the use of the surrogate primary endpoint of the change ... to pre-tax stock compensation expense. use of Non-GAAP Financial Measures Amicus' ... create and build major new enterprises that use technology to improve the way we live, work and ...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

... proprietary product candidates principally for use in the hospital setting, today reported financial ... proprietary product candidates principally for use in the hospital setting. The company is currently ... or result in limitations in the indications for use or the inclusion of unfavorable information in ...

Omeros Appoints New Vice President of Clinical Development

... surgery, OMS302 in a Phase 2 program for use in cataract surgery, and OMS201 in a Phase 1/2 program for use in uroendoscopy. "Dr. Murray brings a ... is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve ...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

... will make the Sweet Enhancers available for use in all packaged food product fields not currently ... the sweet intensity or producing off-tastes. use of S2383 may also result in an improved taste ... flavor ingredient that enables a reduction in the use of salt. The enhancers are being optimized and ...

Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures

... smaller surgical field as a result of electing to use a minimally invasive approach for the procedure. ... include our newly designed 36 mm needles. The use of Quill SRS in laparoscopic gynecology surgery ... post operative issues or complications from the use of Quill SRS in a patient series that had grown ...

Five Questions About Protopic (tacrolimus) Ointment

... who have a normal immune system. Protopic is for use after other prescription medicines have not ... The most common side effects with the use of Protopic are sensation of skin burning or ... (sun lamps or tanning beds). Patients should not use Protopic if they have a skin infection on the ...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

... prescription sleep aid specifically approved for use in the middle of the night at the time a patient ... prescription sleep aid specifically approved for use in the middle of the night at the time a patient ... Intermezzo ((R)) with the FDA; expectations for use of proceeds that may be obtained pursuant to the ...

ERT Reports Second Quarter 2009 Results

... on increased centralization of ECGs, increased use of ePRO in clinical trials and increasing our ... when calling internationally. Please use pass code 71733855. There will be a playback ... when calling internationally. Please use pass code 26054685 for the replay. This ...

IIVS Announces Initiation by EPA of a Pilot Program to Evaluate Non-Animal Eye-Irritation Methods

... EPA has initiated a new program to evaluate the use of non-animal methods to replace the Draize test ... approximately 18-month project encompasses the use of three in vitro assays: the Bovine Corneal Opacity and Permeability test (the use of eyes from cattle recently slaughtered for ...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

... or GAM(TM) delivery and ligand targeting; (2) use of GAM to locally produce proteins capable of ... research and development supporting the use of GAM to deliver bone growth factors. Cardium ... is expected to be further expanded with the use of other genes capable of promoting bone repair, ...

PROTOMED SA Chooses HyperWorks to Simulate Implantable Medical Devices

... implantable medical devices. PROTOMED engineers use CAE to predict physical responses of biological systems to known load conditions and will use HyperWorks to model medical devices for various ... Engineering is happy to work with PROTOMED in its use of simulation for development of medical ...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

... relief of moderate-to-severe acute pain where the use of an opioid is appropriate; OPANA(R) ER tablets ... new regulatory action or lawsuits relating to our use of controlled substances in many of our core ... activities, including promoting the "off-label" use of our products; the loss of branded product ...

Caliper Life Sciences Reports Second Quarter 2009 Results

... five to ten minutes prior to the call and use the participant passcode 64195782. International ... July 30 through August 6, dial 888.286.8010 and use the participant passcode of 38849510. ... - Basic $(0.05) $(0.09) $(0.15) $(0.23) We use the term "adjusted earnings per share" or ...

Sanofi-aventis Announces Second Quarter 2009 Results

... regarding a potential link between Lantus ((R)) use and an increased risk of cancer. The CHMP ... of 10.7% to euro 584 million, driven by its use in adjuvant breast cancer treatment and in ... the Committee for Medicinal Products for Human use (CHMP) of the EMEA issued a positive opinion on ...

SAFC Biosciences(R) Defines Hydrolysate Components That Enhance Chinese Hamster Ovary (CHO) Cell Line Protein Production

... to undefined hydrolysates, has been created for use in CHO, NS0 and Sp2/0 biopharmaceutical ... risk and production variability stemming from the use of undefined or adulterated raw materials in ... Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 ...

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

... bone. Additional information regarding the use of Excellarate for the potential treatment of ... most diabetic wound healing agents or devices in use that require repeated administrations over a long ... or will effectively simplify or expand the use of product candidates or technologies, that the ...

RadMD First to Offer CME-Certified Education and Training For Medical Imaging in Clinical Trials

... "A huge number of clinical trials use medical imaging to demonstrate effectiveness," ... and testing on a variety of topics related to the use of medical imaging in clinical trials. The ... but there are no standards in place to govern the use of medical imaging for this purpose," said Dr. ...

Human Genome Sciences Announces Proposed Public Offering of Common Stock

... ) The Company intends to use net proceeds from the offering for general ... and marketing activities. The Company may also use a portion of the proceeds for the potential ... acquisition or investment. The Company also may use a portion of the net proceeds to repay, ...

Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections

... with Unomedical, a leading manufacturer of single use medical devices used in the treatment of ... in the development and manufacturing of single use devices used in the treatment of diabetes. It has ... Injection Port is a prescription only device for use by people requiring multiple daily, subcutaneous ...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

... Administration (FDA) has granted an emergency use authorization to the company's Focus Diagnostics ... commercial lab test to be granted an emergency use authorization by the FDA for testing for the 2009 ... of receipt of specimen. "This emergency use authorization means that the Influenza A H1N1 ...

Vi typhoid vaccine proves highly effective in young children

... vaccines, Vi polysaccharide, is ideally suited to use in developing countries because it is cheap ... by the World Health Organization for use of Vi vaccines in developing countries, its use has been limited, partly because of doubts about ...

Abbott HIV Test Demonstrates Earlier Disease Detection

... the five panels tested. "The ability to use a blood test to diagnose HIV sooner, in the acute ... HIV Combo (Ag/Ab) assay is not intended for use in blood screening, plasma or tissue donors. The effectiveness of ARCHITECT HIV Combo (Ag/Ab) for use in screening blood, plasma or tissue donors has ...

Schering-Plough Reports Financial Results for 2009 Second Quarter

... and BRIDION (sugammadex), an innovative agent for use in anesthesiology. The company's R&D ... first-in-class adenosine regulating agent for use in heart bypass surgery; and In Animal ... an investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive ...

Quantros ACE Helps East Jefferson General Hospital Achieve Best-in-Class Performance

... General Hospital (EJGH) has achieved through its use of the Quantros Accreditation and Compliance ... and gained access to robust reporting through the use of Quantros ACE," said Janet Davis, PT, MPH, ... than 2,000 healthcare facilities are licensed to use Quantros' web-based technology solutions. ...

Practice makes perfect -- motor memory possible for neuroprosthetic control

... California, Berkeley, taught macaque monkeys to use their own brain signals to move a computer cursor ... and as the monkeys learned to proficiently use the robotic device, the researchers monitored ... ultimate neuroprosthetic device that humans can use to perform many different tasks in a more natural ...

Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres

... for farmers and will further reduce insecticide use while reducing grower risks and enhancing the ... that it has enabled my son and me to reduce the use of insecticides on our farm by 80 percent," said ... corn will allow us to reduce our insecticide use even further to 5 percent of our corn acres, ...

Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)

... "Lyophilized product is the standard end use formulation for commercial use of the product." The lyophilization program was ... and storage. Pharmaceutical companies often use lyophilization to increase the shelf life of ...

EU Committee Approves New Food Applications for Martek's life'sDHA™

... life'sDHA Now Approved for use in Bakery Products, All Dairy Products, Cereal ... and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula, and ... (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek ...

Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo

... This saves microbiology labs from having to use multiple off-line test procedures to obtain ... therapeutics because pharmaceutical companies use the Sensititre system during drug development. ... the most-sophisticated analyses, but are easy to use for operators with varying levels of education ...

Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System

... of subcutaneous sumatriptan and a simple to use needle-free delivery system." Triptans, ... for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar ... cardiovascular disease. Considering the extent of use of sumatriptan in patients with migraine, the ...

New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix

... enable researchers to quickly and effectively use these invaluable resources. ... variables, documents, and analyses to use the analysis browser to identify candidate ... can quickly learn to effectively and efficiently use these resources. The scripts, handouts and other ...

Blackrock Microsystems Obtains Expanded 510(k) to Market NeuroPort System

... NeuroPort System has been expanded to include its use in medical applications beyond brain monitoring. ... under IDE), which is designed for chronic use in people with spinal cord injuries, stroke and ... the NeuroPort System in April 2005, though its use at the time was limited exclusively to acute ...

American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification

... and the HIT Policy Committee about meaningful use and electronic health record certification. The ... be critical to the successful implementation and use of these systems." As we note in our formal ... and experience that already exists about the use and application of health information technology ...

NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China

... perpetual and irrevocable license to use this technology of Dr. Centeno and Regenerative ... -- as announced on May 11, 2009. The first such use is anticipated to be at the Wendeng Orthopedic ... they are young and healthy for their personal use in times of future medical need. The Company has ...

Politicians to Drive on Straw-Based Bioethanol at the Climate Change Conference

... and knowledge within the development and use of enzymes. Facts about ... or wheat straw that can also offset fossil fuel use 100% in the entire operation. Find out more at ... improving our customers' business and the use of our planet's resources. With over 700 products ...